Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases

Abstract Background Liver diseases and related complications are major sources of morbidity and mortality, which places a huge financial burden on patients and lead to nonnegligible social problems. Therefore, the discovery of novel therapeutic drugs for the treatment of liver diseases is urgently r...

Full description

Bibliographic Details
Main Authors: Jianzhi Wu, Guangrui Huang, Yajing Li, Xiaojiaoyang Li
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Chinese Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13020-020-00371-5
_version_ 1828462516718534656
author Jianzhi Wu
Guangrui Huang
Yajing Li
Xiaojiaoyang Li
author_facet Jianzhi Wu
Guangrui Huang
Yajing Li
Xiaojiaoyang Li
author_sort Jianzhi Wu
collection DOAJ
description Abstract Background Liver diseases and related complications are major sources of morbidity and mortality, which places a huge financial burden on patients and lead to nonnegligible social problems. Therefore, the discovery of novel therapeutic drugs for the treatment of liver diseases is urgently required. Aurantii Fructus Immaturus (AFI) and Aurantii Fructus (AF) are frequently used herbal medicines in traditional Chinese medicine (TCM) formulas for the treatment of diverse ailments. A variety of bioactive ingredients have been isolated and identified from AFI and AF, including alkaloids, flavonoids, coumarins and volatile oils. Main body Emerging evidence suggests that flavonoids, especially hesperidin (HD), naringenin (NIN), nobiletin (NOB), naringin (NRG), tangeretin (TN), hesperetin (HT) and eriodictyol (ED) are major representative bioactive ingredients that alleviate diseases through multi-targeting mechanisms, including anti-oxidative stress, anti-cytotoxicity, anti-inflammation, anti-fibrosis and anti-tumor mechanisms. In the current review, we summarize the recent progress in the research of hepatoprotective effects of HD, NIN, NOB, NRG, TN, HT and ED and highlight the potential underlying molecular mechanisms. We also point out the limitations of the current studies and shed light on further in-depth pharmacological and pharmacokinetic studies of these bioactive flavonoids. Conclusion This review outlines the recent advances in the literature and highlights the potential of these flavonoids isolated from AFI and AF as therapeutic agents for the treatment of liver diseases. Further pharmacological studies will accelerate the development of natural products in AFI and AF and their derivatives as medicines with tantalizing prospects in the clinical application.
first_indexed 2024-12-11T02:38:29Z
format Article
id doaj.art-d97a308e19b4400b8cc7759258460f9b
institution Directory Open Access Journal
issn 1749-8546
language English
last_indexed 2024-12-11T02:38:29Z
publishDate 2020-08-01
publisher BMC
record_format Article
series Chinese Medicine
spelling doaj.art-d97a308e19b4400b8cc7759258460f9b2022-12-22T01:23:40ZengBMCChinese Medicine1749-85462020-08-0115111810.1186/s13020-020-00371-5Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseasesJianzhi Wu0Guangrui Huang1Yajing Li2Xiaojiaoyang Li3School of Life Sciences, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineSchool of Life Sciences, Beijing University of Chinese MedicineAbstract Background Liver diseases and related complications are major sources of morbidity and mortality, which places a huge financial burden on patients and lead to nonnegligible social problems. Therefore, the discovery of novel therapeutic drugs for the treatment of liver diseases is urgently required. Aurantii Fructus Immaturus (AFI) and Aurantii Fructus (AF) are frequently used herbal medicines in traditional Chinese medicine (TCM) formulas for the treatment of diverse ailments. A variety of bioactive ingredients have been isolated and identified from AFI and AF, including alkaloids, flavonoids, coumarins and volatile oils. Main body Emerging evidence suggests that flavonoids, especially hesperidin (HD), naringenin (NIN), nobiletin (NOB), naringin (NRG), tangeretin (TN), hesperetin (HT) and eriodictyol (ED) are major representative bioactive ingredients that alleviate diseases through multi-targeting mechanisms, including anti-oxidative stress, anti-cytotoxicity, anti-inflammation, anti-fibrosis and anti-tumor mechanisms. In the current review, we summarize the recent progress in the research of hepatoprotective effects of HD, NIN, NOB, NRG, TN, HT and ED and highlight the potential underlying molecular mechanisms. We also point out the limitations of the current studies and shed light on further in-depth pharmacological and pharmacokinetic studies of these bioactive flavonoids. Conclusion This review outlines the recent advances in the literature and highlights the potential of these flavonoids isolated from AFI and AF as therapeutic agents for the treatment of liver diseases. Further pharmacological studies will accelerate the development of natural products in AFI and AF and their derivatives as medicines with tantalizing prospects in the clinical application.http://link.springer.com/article/10.1186/s13020-020-00371-5Aurantii Fructus ImmaturusAurantii FructusLiver diseasesFlavonoidsHesperidinNaringenin
spellingShingle Jianzhi Wu
Guangrui Huang
Yajing Li
Xiaojiaoyang Li
Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
Chinese Medicine
Aurantii Fructus Immaturus
Aurantii Fructus
Liver diseases
Flavonoids
Hesperidin
Naringenin
title Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
title_full Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
title_fullStr Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
title_full_unstemmed Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
title_short Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
title_sort flavonoids from aurantii fructus immaturus and aurantii fructus promising phytomedicines for the treatment of liver diseases
topic Aurantii Fructus Immaturus
Aurantii Fructus
Liver diseases
Flavonoids
Hesperidin
Naringenin
url http://link.springer.com/article/10.1186/s13020-020-00371-5
work_keys_str_mv AT jianzhiwu flavonoidsfromaurantiifructusimmaturusandaurantiifructuspromisingphytomedicinesforthetreatmentofliverdiseases
AT guangruihuang flavonoidsfromaurantiifructusimmaturusandaurantiifructuspromisingphytomedicinesforthetreatmentofliverdiseases
AT yajingli flavonoidsfromaurantiifructusimmaturusandaurantiifructuspromisingphytomedicinesforthetreatmentofliverdiseases
AT xiaojiaoyangli flavonoidsfromaurantiifructusimmaturusandaurantiifructuspromisingphytomedicinesforthetreatmentofliverdiseases